S2 Ep.3 Early Ovarian Cancer Diagnostics with Ana Jeter from AoA DX

Update: 2022-01-24

Description

In this episode, we spoke Ana Jeter, CBO and co-founder of AoA DX. AoA DX is bringing the first liquid biopsy test that accurately enables early diagnosis of ovarian cancer through the analysis of tumor marker gangliosides.

Comments

In Channel

S2 E4 Rebecca Vaught, CEO and co-founder of Van Heron Labs

2022-02-0856:44

S2 Ep.3 Early Ovarian Cancer Diagnostics with Ana Jeter from AoA DX

2022-01-2438:23

S2 Ep.2 Stopping hiccups with Dr. Ali Seifi from HiccAway

2022-01-1033:46

S2 Ep.1 Advanced Prostheses Made Affordable with Ryan Saavedra from Alt-Bionics

2021-11-2936:01

Episode 8 | Jordan Miller (Volumetric, Inc)

2021-05-1943:24

Episode 7 | Somer Baburek (Hera Biotech)

2021-04-0450:29

Episode 6 | Elizabeth Jaworski (ClickSeq Technologies)

2021-03-0331:54

Episode 5 | Lauren Cornell and Bianca Cerqueira (NovoThelium)

2021-01-3035:58

Episode 4 | Theodore Price (4E Therapeutics, Ted's Brain Science, CerSci Therapeutics)

2021-01-0333:05

Episode 3 | Ramon Coronado (Crown Scientific and Perytor Therapeutics)

2020-11-2941:13

Episode 2 | Diving into digital mental health innovation with Cynthia Phelps (Health eDesigns and InnerAlly)

2020-11-0246:16

Episode 1 | Gigi Kamali (Biome)

2020-09-3027:53

00:00

1.0x

S2 Ep.3 Early Ovarian Cancer Diagnostics with Ana Jeter from AoA DX

#box-pro-ellipsis-176353173249414{-webkit-line-clamp:2;}S2 Ep.3 Early Ovarian Cancer Diagnostics with Ana Jeter from AoA DX

S2 Ep.3 Early Ovarian Cancer Diagnostics with Ana Jeter from AoA DX

Enventure Med

S2 Ep.3 Early Ovarian Cancer Diagnostics with Ana Jeter from AoA DX